Literature DB >> 30169995

Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.

Aziz Khan1,2, Anthony Mathelier1,3, Xuegong Zhang2,4.   

Abstract

Super-enhancers and stretch enhancers represent classes of transcriptional enhancers that have been shown to control the expression of cell identity genes and carry disease- and trait-associated variants. Specifically, super-enhancers are clusters of enhancers defined based on the binding occupancy of master transcription factors, chromatin regulators, or chromatin marks, while stretch enhancers are large chromatin-defined regulatory regions of at least 3,000 base pairs. Several studies have characterized these regulatory regions in numerous cell types and tissues to decipher their functional importance. However, the differences and similarities between these regulatory regions have not been fully assessed. We integrated genomic, epigenomic, and transcriptomic data from ten human cell types to perform a comparative analysis of super and stretch enhancers with respect to their chromatin profiles, cell type-specificity, and ability to control gene expression. We found that stretch enhancers are more abundant, more distal to transcription start sites, cover twice as much the genome, and are significantly less conserved than super-enhancers. In contrast, super-enhancers are significantly more enriched for active chromatin marks and cohesin complex, and more transcriptionally active than stretch enhancers. Importantly, a vast majority of super-enhancers (85%) overlap with only a small subset of stretch enhancers (13%), which are enriched for cell type-specific biological functions, and control cell identity genes. These results suggest that super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers, and importantly, most of the stretch enhancers that are distinct from super-enhancers do not show an association with cell identity genes, are less active, and more likely to be poised enhancers.

Entities:  

Keywords:  Gene regulation; epigenomics; genomics; stretch enhancers; super-enhancers

Mesh:

Substances:

Year:  2018        PMID: 30169995      PMCID: PMC6284781          DOI: 10.1080/15592294.2018.1514231

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  59 in total

1.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

2.  Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells.

Authors:  Jessica Zuin; Jesse R Dixon; Michael I J A van der Reijden; Zhen Ye; Petros Kolovos; Rutger W W Brouwer; Mariëtte P C van de Corput; Harmen J G van de Werken; Tobias A Knoch; Wilfred F J van IJcken; Frank G Grosveld; Bing Ren; Kerstin S Wendt
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-13       Impact factor: 11.205

Review 3.  Enhancer function: new insights into the regulation of tissue-specific gene expression.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2011-03-01       Impact factor: 53.242

4.  Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development.

Authors:  Stefan Bonn; Robert P Zinzen; Charles Girardot; E Hilary Gustafson; Alexis Perez-Gonzalez; Nicolas Delhomme; Yad Ghavi-Helm; Bartek Wilczyński; Andrew Riddell; Eileen E M Furlong
Journal:  Nat Genet       Date:  2012-01-08       Impact factor: 38.330

5.  Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers.

Authors:  Denes Hnisz; Jurian Schuijers; Charles Y Lin; Abraham S Weintraub; Brian J Abraham; Tong Ihn Lee; James E Bradner; Richard A Young
Journal:  Mol Cell       Date:  2015-03-19       Impact factor: 17.970

6.  Selective inhibition of tumor oncogenes by disruption of super-enhancers.

Authors:  Jakob Lovén; Heather A Hoke; Charles Y Lin; Ashley Lau; David A Orlando; Christopher R Vakoc; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 7.  Modification of enhancer chromatin: what, how, and why?

Authors:  Eliezer Calo; Joanna Wysocka
Journal:  Mol Cell       Date:  2013-03-07       Impact factor: 17.970

8.  Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes.

Authors:  Kaifu Chen; Zhong Chen; Dayong Wu; Lili Zhang; Xueqiu Lin; Jianzhong Su; Benjamin Rodriguez; Yuanxin Xi; Zheng Xia; Xi Chen; Xiaobing Shi; Qianben Wang; Wei Li
Journal:  Nat Genet       Date:  2015-08-24       Impact factor: 38.330

9.  Dalliance: interactive genome viewing on the web.

Authors:  Thomas A Down; Matias Piipari; Tim J P Hubbard
Journal:  Bioinformatics       Date:  2011-01-19       Impact factor: 6.937

Review 10.  Super Enhancers in Cancers, Complex Disease, and Developmental Disorders.

Authors:  Adrienne R Niederriter; Arushi Varshney; Stephen C J Parker; Donna M Martin
Journal:  Genes (Basel)       Date:  2015-11-09       Impact factor: 4.096

View more
  18 in total

1.  Combinatorial chromatin dynamics foster accurate cardiopharyngeal fate choices.

Authors:  Claudia Racioppi; Keira A Wiechecki; Lionel Christiaen
Journal:  Elife       Date:  2019-11-20       Impact factor: 8.140

2.  High-performance method for identification of super enhancers from ChIP-Seq data with configurable cloud virtual machines.

Authors:  Natalia N Orlova; Olga V Bogatova; Alexey V Orlov
Journal:  MethodsX       Date:  2020-11-28

Review 3.  Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.

Authors:  Seng Chuan Tang; Udhaya Vijayakumar; Ying Zhang; Melissa Jane Fullwood
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 4.  Integrated Analysis of Whole Genome and Epigenome Data Using Machine Learning Technology: Toward the Establishment of Precision Oncology.

Authors:  Ken Asada; Syuzo Kaneko; Ken Takasawa; Hidenori Machino; Satoshi Takahashi; Norio Shinkai; Ryo Shimoyama; Masaaki Komatsu; Ryuji Hamamoto
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

Review 5.  Perturbing Enhancer Activity in Cancer Therapy.

Authors:  Feda H Hamdan; Steven A Johnsen
Journal:  Cancers (Basel)       Date:  2019-05-07       Impact factor: 6.639

Review 6.  Master control: transcriptional regulation of mammalian Myod.

Authors:  Fiona C Wardle
Journal:  J Muscle Res Cell Motil       Date:  2019-07-12       Impact factor: 2.698

7.  Integrative modeling reveals key chromatin and sequence signatures predicting super-enhancers.

Authors:  Aziz Khan; Xuegong Zhang
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

Review 8.  Super-enhancers: critical roles and therapeutic targets in hematologic malignancies.

Authors:  Yunlu Jia; Wee-Joo Chng; Jianbiao Zhou
Journal:  J Hematol Oncol       Date:  2019-07-16       Impact factor: 17.388

9.  Super-enhancers in transcriptional regulation and genome organization.

Authors:  Xi Wang; Murray J Cairns; Jian Yan
Journal:  Nucleic Acids Res       Date:  2019-12-16       Impact factor: 16.971

10.  Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer.

Authors:  Simeng Wen; Yundong He; Liewei Wang; Jun Zhang; Changyi Quan; Yuanjie Niu; Haojie Huang
Journal:  Oncogene       Date:  2020-09-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.